E Fund Management Co., Ltd. Karyopharm Therapeutics Inc. Transaction History

E Fund Management Co., Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$2.84 - $3.92 $43,579 - $60,152	15,345 Added 42.04%	51,849 $202,000
Q4 2022 Feb 14, 2023	SELL	$2.48 - $5.93 $23,361 - $55,860	-9,420 Reduced 20.51%	36,504 $124,000
Q3 2022 Nov 14, 2022	SELL	$4.08 - $5.82 $27,527 - $39,267	-6,747 Reduced 12.81%	45,924 $251,000
Q2 2022 Aug 15, 2022	BUY	$4.15 - $8.37 $50,169 - $101,184	12,089 Added 29.79%	52,671 $238,000
Q1 2022 May 12, 2022	BUY	$5.91 - $14.38 $166,608 - $405,386	28,191 Added 227.51%	40,582 $299,000
Q4 2021 Feb 11, 2022	SELL	$5.21 - $8.61 $42,362 - $70,007	-8,131 Reduced 39.62%	12,391 $80,000
Q3 2021 Nov 12, 2021	BUY	$4.45 - $10.63 $41,198 - $98,412	9,258 Added 82.19%	20,522 $119,000
Q1 2021 May 12, 2021	BUY	$9.85 - $17.69 $110,950 - $199,260	11,264 New	11,264 $118,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.